Invesco Ltd. Praxis Precision Medicines, Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.8 - $4.98 $108 - $677	-136 Reduced 1.28%	10,504 $8,000
Q4 2022 Feb 13, 2023	SELL	$1.88 - $36.45 $4,235 - $82,121	-2,253 Reduced 17.47%	10,640 $25,000
Q3 2022 Nov 14, 2022	SELL	$2.5 - $37.95 $240 - $3,643	-96 Reduced 0.74%	12,893 $29,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $11.34 $857 - $5,556	490 Added 3.92%	12,989 $32,000
Q1 2022 May 16, 2022	BUY	$10.21 - $20.29 $4,155 - $8,258	407 Added 3.37%	12,499 $127,000
Q4 2021 Feb 14, 2022	BUY	$16.76 - $22.99 $19,827 - $27,197	1,183 Added 10.84%	12,092 $239,000
Q3 2021 Nov 15, 2021	BUY	$13.15 - $22.56 $143,453 - $246,107	10,909 New	10,909 $201,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.